Concerns of chemical industries with respect to Covid-19
Just as supply chains are being disrupted by outbreaks in key regions, demand may fall due to uncertainty in the global economy and capital markets.
There’s no one-size-fits-all approach to the current environment — and it’s certainly not business as usual. Most companies already have business continuity plans, but those may not address the fast-moving and unknown variables of an outbreak like COVID-19.
The industry could potentially be hit hard by the COVID-19 outbreak on numerous fronts: lowered demand and productivity, operational and supply chain disruptions, potentially tightening credit markets and the health of their workforce.
The industry may be especially vulnerable given that the bulk of its production workforce is in on-site jobs that cannot be done remotely. Additionally, given the nature of the industry, companies may need to consider how to create social distancing in workplaces that are often worker-dense.
On top of this, many companies should prepare for major global supply chain and other distribution disruptions. They should also likely expect that supply chain partners may experience their own challenges and may not be able to fulfill orders on time — or at all — during the crisis.
Finally, expect slackening demand for products resulting from some impacted industries, including automotive and industrial products. Yet, we could simultaneously see a continued demand from other end-users, such as producers of personal health and household products.
Chemicals companies, like many other manufacturers, are exposed on multiple fronts to the disruption wrought by the COVID-19 outbreak. In the immediate future, they may grapple with keeping their workforce and their families safe, while keeping operations in place as much as possible.
Commodity chemicals companies may have to cope with feedstock price volatility, supply chain and logistics challenges, and unpredictable customer demand. And the industry may well need to find alternatives to the sector's reliance on inputs from China-based suppliers.
In the medium term, demand for products ranging from automobiles to some consumer products could likely decrease. Small pockets of the industry may benefit — such as those that produce chemicals included in sanitation products or certain plastics used in medical devices — but the vast majority of the industry may likely be negatively impacted due to significant reliance on Asia for supply, as well as lower global demand in end-use markets. Many in the industry may put into place measures to ride out this crisis by helping contain the effect of the virus on their workforce, temporarily closing facilities, maintaining cash liquidity and shoring up operations on numerous fronts.
Looking ahead to containment of the virus and an eventual economic recovery, chemicals companies should consider what the industry recovery may look like, and plan for what steps they can take now to position themselves as well as possible in a post-COVID-19 world.
Looking for chemical products? Let suppliers reach out to you!
2026-07-18
-
Fine Chemicals Industry Overview Dec.2025
Insight into Structural Shifts, Capturing Long-Term Value in Fine Chemicals. Available for Permanent Download.Published in: Jan. 2026
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
Pfizer's paxlovid reduces the risk of COVID-19 by 26%
-
The battle between Pfizer and Gilead over COVID-19 drugs will continue
-
1200 cases were newly prescribed by Junshi Biologic for mild to moderate disease
-
Twenty-five COVID-19 Vaccines In China Enter Stages Of Clinical Trials
-
Pfizer to Increase Production Capacity of COVID-19 Oral Drugs, Invest 120 Million US Dollars
-
Anke Bio and Afana Collaborate on mRNA Vaccines for Mutant Strains Such as COVID-19 Omicron
-
As Low as $25/session! Pfizer's COVID-19 Oral Drug Paxlovid Generic Drug Price Released
-
Survey On Corona Deaths By Country
-
COVID-19 Drug Remdesivir Approved for Infants And Young Children
-
Roche's Q1 Performance Increases by 10%, And Total Revenue for the Year May Slow Down Due to COVID-19, Biosimilar Competition
Recommend Reading
-
Backed by Hanwha and DL, Still No Rescue? South Korea's Third-Largest Ethylene Giant on the Brink of Collapse
-
Clariant SynDane Catalyst Performs Excellently at Wanhua Maleic Anhydride Plant
-
Röhm Launches New Sulfuric Acid Plant
-
TDI Supply Tightens and Prices Surge: Can Cangzhou Dahua Reap the "Chemical Dividend"?
-
Air Liquide's Molybdenum Manufacturing Plant in South Korea is Operational
-
Why Did Chemical Raw Materials Unexpectedly Escape the Latest Round of U.S. 301 Tariffs on 60 Economies?
-
Supply-Demand Gap Widens, Lithium Carbonate Prices Approach Year-to-Date High
-
Premium Global Chemical Sourcing Requests (20-24 Oct 2025)
-
Ethyl Acetate Market Prices Adjusted and Risen
-
September Hydrogen Peroxide Market Warms Up
- Hot Searches
- chemical formula hydrogen sulphide
- methyl alcohol formula
- magnesium pyrophosphate formula
- hydralazine trade name
- potassium sulfide chemical formula
- formula for hydrogen sulphide
- n2o5 compound name
- lacunar stroke
- aluminum carbonate formula
- sulfur trioxide formula
- silver sulfide
- clotrimazole tablet